P&C Top Line Growth: 8.6% increase, driven by pricing and non-motor volume growth. Average Annual Premium Growth: Approximately 6%, with motor premiums growing around 8%. Combined Ratio: Reported below 90%, with a target of around 94.5% by 2027. Life Net Flows: EUR3 billion in the first quarter, with EUR1.4 billion in protection & health and EUR1.2 billion in hybrid & unit-linked. Surrenders in Italy: Down 20% year-on-year in the first quarter. New Business Margin: Increased by 26 basis points compared to last year. CSM Release Ratio: 2.5%, with full-year 2025 guidance at the mid-high end of 8% to 10%. P&C Operating Insurance Service Result: EUR180 million growth quarter-on-quarter, a 25% increase year-on-year. Solvency 2 Ratio: 210%, reflecting strong capital generation and disciplined asset allocation. Adjusted Earnings Per Share Growth: 9.4% year-on-year. Warning! GuruFocus has detected 3 Warning Sign with ARZGF. Release Date: May 22, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Generali (ARZGF) reported strong growth in its Property & Casualty (P&C) segment, with an 8.6% increase in the top line, driven by pricing and volume growth in non-motor segments. The company achieved a reported combined ratio below 90%, indicating strong underwriting performance and cost management. Life net flows reached EUR 3 billion in the first quarter, with significant contributions from protection & health and hybrid & unit-linked products. Generali (ARZGF) maintained a robust capital position with a Solvency 2 ratio of 210%, reflecting strong capital generation and disciplined asset allocation. The company is on track with its Lifetime Partner 27: Driving Excellence plan, focusing on strategic growth areas such as health, climate, and SME markets. Negative Points Generali (ARZGF) experienced negative operating variances of EUR 77 million due to a regulation change on stamp duty in Italy, impacting the Solvency 2 ratio. The company faced challenges in its Life segment with surrenders in Italy not yet returning to normal levels, although they are on a positive trajectory. The P&C segment's combined ratio benefited from positive seasonality, which may not be sustainable throughout the year. Economic variances were only moderately positive due to negative returns from non-European equities and currency depreciation. The company anticipates project costs related to strategic initiatives, which could increase expenses by EUR 25 million to EUR 50 million compared to 2024. Story Continues Q & A Highlights Q: Can you provide details on the P&C combined ratio and any man-made losses in the quarter? A: Cristiano Borean, Group CFO, explained that the first quarter saw EUR35 million in man-made losses compared to EUR54 million in the first quarter of 2024. The impact of man-made losses is expected to be around 0.7% of the attritional loss ratio, with some volatility expected. The company maintains a strict underwriting discipline to manage this volatility. Q: Could you elaborate on pricing trends across different geographies, particularly in Germany and Spain? A: Giulio Terzariol, CEO of Insurance, noted that the average premium in the motor line is increasing by about 8%, with a risk premium increase of 3%, resulting in a favorable spread. In Germany, rate increases are in double digits, and Spain has seen significant improvements with double-digit rate increases and a 5 percentage-point spread over the risk premium. Q: What are the key focus areas for non-motor products, and how do they compare to motor in terms of combined ratio? A: Marco Maria Sesana, General Manager, stated that the focus is on traditional products like family and house protection, with growth in health and SME cyber risk protection. Non-motor products have a better combined ratio, around 62%, compared to motor at 70%. Q: Can you provide guidance on the full-year investment result for the non-life business? A: Cristiano Borean confirmed a full-year guidance of EUR950 million for the P&C investment result, with expectations of improvement in the remainder of the year due to factors like the Argentina effect and dividend distributions. Q: How are lapses in Italy affecting the new business margin, and what is the outlook for commercial incentives? A: Marco Maria Sesana indicated that lapses are decreasing but not yet at 2020 levels due to the current interest rate environment. The new business margin guidance remains between 5.25% and 5.75%. Commercial incentives are being scaled back to focus on quality volume. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
Generali (ARZGF) Q1 2025 Earnings Call Highlights: Strong Growth in P&C and Life Segments ...
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...